Skip to main content
SpringerLink
Log in

Medication adherence and persistence: A comprehensive review

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Estimates of adherence to long-term medication regimens range from 17% to 80%, and nonadherence (or nonpersistence) can lead to increased morbidity, mortality, and healthcare costs. Multifaceted interventions that target specific barriers to adherence are most effective, because they address the problems and reinforce positive behaviors. Providers must assess their patients’ understanding of the illness and its treatment, communicate the benefits of the treatment, assess their patients’ readiness to carry out the treatment plan, and discuss any barriers or obstacles to adherence that patients may have. A positive, supporting, and trusting relationship between patient and provider improves adherence. Individual patient factors also affect adherence. For example, conditions that impair cognition have a negative impact on adherence. Other factors—such as the lack of a support network, limited English proficiency, inability to obtain and pay for medications, or severe adverse effects or the fear of such effects—are all barriers to adherence. There are multiple reasons for nonadherence or nonpersistence; the solution needs to be tailored to the individual patient’s needs. To have an impact on adherence, healthcare providers must understand the barriers to adherence and the methods or tools needed to overcome them. This report describes the barriers to medication adherence and persistence and interventions that have been used to address them; it also identifies interventions and compliance aids that practitioners and organizations can implement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Demyttenaere K. Noncompliance with antidepressants: who’s to blame? Int Clin Psychopharmacol. 1998;13(suppl 2):S19-S25.

    Article  PubMed  Google Scholar 

  2. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Nat Cancer Inst. 2002;94:652–661.

    PubMed  Google Scholar 

  3. Schoen MD, Di Domenico RJ, Connor SE, Dischler JE, Bauman JL. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy. 2001;21: 1455–1463.

    Article  PubMed  CAS  Google Scholar 

  4. Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38:574–585.

    CAS  Google Scholar 

  5. Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57:77–83.

    Article  PubMed  CAS  Google Scholar 

  6. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 1994;29:172–177.

    PubMed  CAS  Google Scholar 

  7. Lesaffre E, Kocmanova D, Lemos PA, Disco CM, Serruys PW. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. Clin Ther. 2003; 25:2431–2447.

    Article  PubMed  Google Scholar 

  8. Balkrishnan R, Christensen DB. Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. J Asthma. 2000;37:511–517.

    Article  PubMed  CAS  Google Scholar 

  9. Lecompte D, Pelc I. A cognitive-behavioral program to improve compliance with medication in patients with schizophrenia. Int J Ment Health. 1996;25:51–56.

    Google Scholar 

  10. Rzewuska M. Drug maintenance treatment compliance and its correlation with the clinical picture and course of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 26:811–814.

  11. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996;312:345–349.

    PubMed  CAS  Google Scholar 

  12. Lin EH, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25:303–310.

    Article  PubMed  Google Scholar 

  13. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60:904–912.

    Article  PubMed  Google Scholar 

  14. Rapoff MA, Belmont J, Lindsley C, Olson N, Morris J, Padur J. Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health Psych. 2002;21:620–623.

    Article  Google Scholar 

  15. Razali SM, Hasanah CI, Khan UA, Subramaniam M. Psychosocial interventions for schizophrenia. Ment Health. 2000;9:283–289.

    Article  Google Scholar 

  16. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction. 1995;90:415–424.

    Article  PubMed  CAS  Google Scholar 

  17. Margolin A, Avants S, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manualguided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003; 22:223–228.

    Article  PubMed  Google Scholar 

  18. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res. 2004;13:69–89.

    Article  PubMed  Google Scholar 

  19. Schmaling KB, Blume AW, Afari N. A randomized controlled pilot study of motivational interviewing to change attitudes about adherence to medications for asthma. J Clin Psychol Med Settings. 2001;8:167–172.

    Article  Google Scholar 

  20. Ngoh LN, Shepherd, MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Educ Couns. 1997; 31:245–261.

    Article  PubMed  CAS  Google Scholar 

  21. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Cardiac Fail. 2003;9:404–411.

    Article  Google Scholar 

  22. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis. 1999;187:53–55.

    Article  PubMed  CAS  Google Scholar 

  23. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241–247.

    Article  PubMed  CAS  Google Scholar 

  24. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026–1031.

    Article  PubMed  CAS  Google Scholar 

  25. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ. 1999;319:612–615.

    PubMed  CAS  Google Scholar 

  26. Tan AS, Yong LS, Wan S, Wong ML. Patient education in the management of diabetes mellitus. Singapore Med J. 1997;38:156–160.

    PubMed  CAS  Google Scholar 

  27. Rand CS, Nides M, Cowles MK, Wise RA, Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1995;152: 580–588.

    PubMed  CAS  Google Scholar 

  28. Dixon L, Weiden P, Torres M, Lehman A. Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry. 1997;154:1302–1304.

    PubMed  CAS  Google Scholar 

  29. Gani F, Pozzi E, Crivellaro MA, et al. The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy. 2001;56:65–68.

    Article  PubMed  CAS  Google Scholar 

  30. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol. 2000;50:172–175.

    Article  PubMed  CAS  Google Scholar 

  31. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108:20–27.

    Article  PubMed  CAS  Google Scholar 

  32. Stewart AV, Eales CJ, Davis KA. Effect of a telephonic intervention on the adherence of patients with hypertension. S Afr J Physiother. 2003;5:29–36.

    Google Scholar 

  33. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218–226.

    Article  PubMed  Google Scholar 

  34. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19:860–869.

    Article  PubMed  CAS  Google Scholar 

  35. Bukstein DA, Bratton DL, Firriolo KM, et al. Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study. J Asthma. 2003;4:475–485.

    Article  CAS  Google Scholar 

  36. Doren M, Reuther G, Minne HW, Schneider HP. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol. 1995;173:1446–1451.

    Article  PubMed  CAS  Google Scholar 

  37. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 1996;10:1029–1033.

    Article  PubMed  CAS  Google Scholar 

  38. Mounier-Vehier C, Bernaud C, Carre A, Lequeuche B, Hotton JM, Charpentier JC. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release. Am J Hypertens. 1998;11(4 pt 1):478–486.

    Article  PubMed  CAS  Google Scholar 

  39. Stoloff SW, Stempel DA, Meyer J, Stanford RH, CarranzaRosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004;113:245–251.

    Article  PubMed  Google Scholar 

  40. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail. 2003;9:324–332.

    Article  PubMed  CAS  Google Scholar 

  41. Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther. 1998;36:849–861.

    Article  PubMed  CAS  Google Scholar 

  42. Frick PA, Lavreys L, Mandaliya K, Kreiss JK. Impact of an alarm device on medication compliance in women in Mombasa, Kenya. Inter J STD AIDS. 2001;12:329–333.

    Article  CAS  Google Scholar 

  43. Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003;9:70–80.

    PubMed  Google Scholar 

  44. Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates: a randomized controlled trial. JAMA. 1999;28:646–650.

    Article  Google Scholar 

  45. Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc. 1996;67:654–658.

    PubMed  CAS  Google Scholar 

  46. Perri M, Martin BC, Pritchard FL. Improving medication compliance: a practical intervention. J Pharm Technol. 1995;11:167–172.

    Google Scholar 

  47. Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307–315.

    PubMed  CAS  Google Scholar 

  48. Naunton M, Peterson GM. Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res. 2003;33:176–182.

    Google Scholar 

  49. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101: 270–276.

    Article  PubMed  CAS  Google Scholar 

  50. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. BrJClin Pharmacol. 1997;44:163–165.

    CAS  Google Scholar 

  51. Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999;159:2312–2316.

    Article  PubMed  CAS  Google Scholar 

  52. Okonkwo PO, Akpala CO, Okafor HU, Mbah AU, Nwaiwu O. Compliance to correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Trans R Soc Trop Med Hyg. 2001;95:320–324.

    Article  PubMed  CAS  Google Scholar 

  53. Putnam DE, Finney JW, Barkley PL, Bonner MJ. Enhancing commitment improves adherence to a medical regimen. J Consul Clin Psychol. 1994;62:191–194.

    Article  CAS  Google Scholar 

  54. Berg J, Dunbar-Jacob J, Sereika SM. An evaluation of a self-management program for adults with asthma. Clin Nurs Res. 1997;6:225–238.

    Article  PubMed  CAS  Google Scholar 

  55. Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ. 1995;310:1229–1231.

    PubMed  CAS  Google Scholar 

  56. Mehta S, Moore RD, Graham, NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665–1670.

    Article  PubMed  CAS  Google Scholar 

  57. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999;33:281–288.

    Article  PubMed  CAS  Google Scholar 

  58. Van Servellen G, Carpio F, Lopez M, et al. Program to enhance health literacy and treatment adherence in low-income HIV-infected Latino men and women. AIDS Patient Care STDs. 2003; 17:581–594.

    Article  PubMed  Google Scholar 

  59. Agarwal MR, Sharma VK, KishoreKumar KV, Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Social Psychiatry. 1998;44:92–106.

    Article  CAS  Google Scholar 

  60. Branin, JJ. Correlates of Strategy Use in Medication Adherence Among Older Adults [dissertation]. Claremont, Calif: Claremont Graduate University; 2003.

    Google Scholar 

  61. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286–290.

    Article  PubMed  CAS  Google Scholar 

  62. Daniels DE, Rene AA, Daniels VR. Race: an explanation of patient compliance—fact or fiction? J Nat Med Assoc. 1994;86:20–25.

    CAS  Google Scholar 

  63. DegliEsposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens. 2002;16:439–444.

    Article  CAS  Google Scholar 

  64. Peters KF, Horne R, Kong F, Francomano CA, Biesecker BB. Living with Marfan syndrome, II: medication adherence and physical activity modification. Clin Genet. 2001;60:283–292.

    Article  PubMed  CAS  Google Scholar 

  65. Van Servellen G, Brown JS, Lombardi E, Herrera G. Health literacy in low-income Latino men and women receiving antiretroviral therapy in community-based treatment centers. AIDS Patient Care STDs. 2003;17:283–298.

    Article  PubMed  Google Scholar 

  66. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDs. 2002;16:599–608.

    Article  PubMed  Google Scholar 

  67. Ayres A, Hoon PW, Franzoni JB, et al. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res. 1994;38:393–402.

    Article  PubMed  CAS  Google Scholar 

  68. Brus H, vande Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Counsel. 1999;36:57–64.

    Article  CAS  Google Scholar 

  69. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000:61:549–555.

    Article  PubMed  CAS  Google Scholar 

  70. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:110–117.

    PubMed  CAS  Google Scholar 

  71. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15:631–645.

    PubMed  CAS  Google Scholar 

  72. Erlen JA, Sereika SM, Cook RL, Hunt SC. Adherence to antiretroviral therapy among women with HIV infection. J Obstet Gynecol Neonatal Nurs. 2002;31:470–477.

    Article  PubMed  Google Scholar 

  73. Evangelista L, Doering LV, Dracup K, Westlake C, Hamilton M, Fonarow, GC. Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs. 2003;18:197–206.

    Article  PubMed  Google Scholar 

  74. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929–2933.

    Article  PubMed  CAS  Google Scholar 

  75. Kyngas H. Compliance with health regimens of adolescents with epilepsy. Seizure. 2000;9: 598–604.

    Article  PubMed  CAS  Google Scholar 

  76. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267–273.

    Article  PubMed  CAS  Google Scholar 

  77. Gago C, Gruss E, Gonzalez S, et al. Compliance of haemodialysis patients with prescribed medication. EDTNA ERCA J. 2000;26:4–6.

    Google Scholar 

  78. Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. J Med Assoc Thail. 2003;86:46–51.

    Google Scholar 

  79. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Nat Med Assoc. 1999;91:439–446.

    CAS  Google Scholar 

  80. Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36:514–518.

    Article  PubMed  Google Scholar 

  81. Wagner G. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials. 2003;4:269–281.

    Article  PubMed  Google Scholar 

  82. Pettinger MB, Waclawiw MA, Davis KB, et al. Compliance to multiple interventions in a high risk population. Ann Epidemiol. 1999;9:408–418.

    Article  PubMed  CAS  Google Scholar 

  83. Van Servellen G, Chang B, Garcia L, Lombardi E. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDs. 2002;16:269–281.

    Article  PubMed  Google Scholar 

  84. Cohen I, Rogers P, Burke V, Beilin LJ. Predictors of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women. J Clin Pharm Ther. 1998;23:423–432.

    Article  PubMed  CAS  Google Scholar 

  85. Embry LM. Predictors of Treatment Adherence in Pediatric Cancer Patients [dissertation]. Hattiesburg, Miss: University of Southern Mississippi; 2003.

    Google Scholar 

  86. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care. 1998;12:196–202.

    Article  PubMed  CAS  Google Scholar 

  87. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs. 1999;13:185–197.

    Article  PubMed  CAS  Google Scholar 

  88. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of adherence to antiretroviral therapy. J AIDS. 2001;28:47–58.

    CAS  Google Scholar 

  89. Anastasio GD, Little JM Jr, Robinson MD, Pettice YL, Leitch BB, Norton HJ. Impact of compliance and side effects on the clinical outcome of patients treated with oral erythromycin. Pharmacotherapy. 1994;14:229–234.

    PubMed  CAS  Google Scholar 

  90. Bruckert E, Simonetta C, Giral P. Compliance with fluvastatin treatment: characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team. J Clin Epidemiol. 1999;52:589–594.

    Article  PubMed  CAS  Google Scholar 

  91. Fraser C, Hadjimichael O, Vollmer T. Predictors of adherence to copaxone therapy in individuals with relapsing-remitting multiple sclerosis. J Neurosci Nurs. 2001;33:231–239.

    PubMed  CAS  Google Scholar 

  92. Cooper AE, Hanrahan P, Luchins DJ. Compliance with atypical antipsychotic regimens. Drug Benefit Trends. 2003;15:34–38.

    Google Scholar 

  93. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88–90.

    Article  PubMed  Google Scholar 

  94. Carrieri MP, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Inter J Behav Med. 2003;10:1–14.

    Article  CAS  Google Scholar 

  95. Gordillo V, delAmo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS Care. 1999;13:1763–1769.

    CAS  Google Scholar 

  96. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997; 54:531–533.

    PubMed  CAS  Google Scholar 

  97. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002; 17:504–511.

    Article  PubMed  Google Scholar 

  98. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615–622.

    Article  PubMed  CAS  Google Scholar 

  99. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis. 1996:84:653–659.

    Article  Google Scholar 

  100. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res. 2003;63:49–58.

    Article  PubMed  Google Scholar 

  101. Conway SP, Pond MN, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis. Thorax. 1996;51:29–33.

    PubMed  CAS  Google Scholar 

  102. Walsh JC, Horne R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: patients’ perspectives provide evidence of multiple causes. AIDS Care. 2001;13:709–720.

    Article  PubMed  CAS  Google Scholar 

  103. Auamnoy T. Self-efficacy and Non-adherence in Post-renal Transplant Patients [dissertation]. Iowa City, Iowa: University of Iowa; 2000.

    Google Scholar 

  104. Christensen AJ, Moran PJ, Lawton WJ, Stallman D, Voigts AL. Monitoring attentional style and medical regimen adherence in hemodialysis patients. Health Psych. 1997;16:256–262.

    Article  CAS  Google Scholar 

  105. Dodds JA. Anger, Hostility and Psychological Reactance: Implications for Intervention and Medical Adherence in the Coronary Patient [dissertation]. Kent, Ohio: Kent State University; 1997.

    Google Scholar 

  106. Penkower L, Dew MA, Ellis D, Sereika SM, Kitutu JM, Shapiro R. Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients. Am J Transplant. 2003;3:1418–1425.

    Article  PubMed  Google Scholar 

  107. Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci. 1998; 43:1133–1137.

    PubMed  CAS  Google Scholar 

  108. Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Manag Care. 1997;3:1693–1698.

    PubMed  CAS  Google Scholar 

  109. Laidlaw JK, Beeken JE, Whitney FW, Reyes AA. Contracting with outpatient hemodialysis patients to improve adherence to treatment. Anna J. 1999;26:37–40.

    PubMed  CAS  Google Scholar 

  110. Segal E, Tamir A, Ish-Shalom S. Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J. 2003;5:859–862.

    PubMed  Google Scholar 

  111. Malcolm SE, Ng JJ, Rosen RK, Stone VE. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003;15:251–261.

    Article  PubMed  CAS  Google Scholar 

  112. McDonald-Miszczak L, Maki SA, Gould ON. Self-reported medication adherence and health status in late adulthood: the role of beliefs. Exp Aging Res. 2000;26:189–207.

    Article  PubMed  CAS  Google Scholar 

  113. Budd RJ, Hughes IC, Smith JA. Health beliefs and compliance with antipsychotic medication. BrJClin Psychol. 1996;35:393–397.

    Google Scholar 

  114. Hargrave R, Remler MP. Noncompliance. J Nat Med Assoc. 1996;88:7, 11.

    CAS  Google Scholar 

  115. Lin CC, Liang CC. The relationship between health locus of control and compliance of hemodialysis patients. Kaohsiung J Med Sci. 1997;13:243–254.

    PubMed  CAS  Google Scholar 

  116. Demyttenaere K, Mesters P, Boulanger B, et al. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. J Affect Disord. 2001;65:243–252.

    Article  PubMed  CAS  Google Scholar 

  117. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19:279–290.

    Article  PubMed  CAS  Google Scholar 

  118. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10:135–140.

    Article  PubMed  CAS  Google Scholar 

  119. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12:387–398.

    Article  PubMed  CAS  Google Scholar 

  120. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders: reasons and remedies. CNS Drugs. 1998;9:457–471.

    Article  Google Scholar 

  121. Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158:29–35.

    Article  PubMed  CAS  Google Scholar 

  122. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication non-compliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000; 51:216–222.

    Article  PubMed  CAS  Google Scholar 

  123. Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18:401–409.

    Article  PubMed  CAS  Google Scholar 

  124. Hausman A. Taking your medicine: relational steps to improving patient compliance. Health Market Q. 2001;19:49–71.

    Article  CAS  Google Scholar 

  125. Chadwick NB. The Therapeutic Alliance, Awareness, and Medication Compliance in the Treatment of Schizophrenia [dissertation]. Augusta, Ga: Medical College of Georgia; 2001.

    Google Scholar 

  126. Fenichel A. The Relationship Between Health Care Clinicians’ Relational Abilities and Psychosocial Orientation to Patient Care, and Patient Adherence With Medical Treatment [dissertation]. New York, NY: Columbia University; 1999.

    Google Scholar 

  127. Levine AM. Antiretroviral therapy: adherence. Clin Care Options HIV Online J. 1998;4:1–10.

    Google Scholar 

  128. Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist. 1993; 33:772–781.

    PubMed  CAS  Google Scholar 

  129. Kasl SA, Cobb S. Health behavior, illness behavior, and sick role behavior, I: health and illness behavior. Arch Environ Health. 1966;12:246–266.

    PubMed  CAS  Google Scholar 

  130. Carroll KM, Ball SA, Nich C, et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry. 2001;58:755–761.

    Article  PubMed  CAS  Google Scholar 

  131. Cox LE. The Relative Influence of Social Support on the Medication Compliance of People With HIV Infection [dissertation]. Richmond, Va: Virginia Commonwealth University; 1998.

    Google Scholar 

  132. Moore SJ. Individuals’ Beliefs Concerning Adherence to Prescribed Antihypertensive Medication Regimens [dissertation]. Bloomington, Ind: Indiana University School of Nursing; 1995.

    Google Scholar 

  133. Bastardo YM, Kimberlin CL. Predicting adherence to antiretroviral therapy: an application of an extended theory of reasoned action (APS-P-203). International Pharmaceutical Federation— World Congress. 2002;62:73.

    Google Scholar 

  134. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119–124.

    Article  PubMed  CAS  Google Scholar 

  135. Cohen NL, Parikh SV, Kennedy SH. Medication compliance in mood disorders: relevance of the health belief model and other determinants. Prim Care Psychiatry. 2000;6:101–110.

    Article  Google Scholar 

  136. Scott J. Using health belief models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neuropsychobiology. 2002;46(suppl 1):13–15.

    Article  PubMed  Google Scholar 

  137. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617–629.

    Article  PubMed  CAS  Google Scholar 

  138. Dracup KA, Meleis AI. Compliance: an interactionist approach. Nurs Res. 1982;31:31–36.

    Article  PubMed  CAS  Google Scholar 

  139. Christensen AJ, Wiebe JS, Lawton WJ. Cynical hostility, powerful others control expectancies, and patient adherence in hemodialysis. Psychosom Med. 1997;59:307–312.

    PubMed  CAS  Google Scholar 

  140. Berg J. An Evaluation of a Self-management Program for Adults With Asthma [thesis]. Pittsburgh, Pa: University of Pittsburgh; 1995.

    Google Scholar 

  141. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000:22:858–871.

    Article  PubMed  CAS  Google Scholar 

  142. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: The Guilford Press; 2002.

    Google Scholar 

  143. Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. J Am Pharm Assoc. 2004; 44:45–545.

    Article  Google Scholar 

  144. O’Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 2003;327:834–838.

    Article  PubMed  Google Scholar 

  145. Sellwood W, Barrowclough C, Tarrier N, Quinn J, Mainwaring J, Lewis S. Needs-based cognitivebehavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. Acta Psychiatr Scand. 2001;104:346–355.

    Article  PubMed  CAS  Google Scholar 

  146. Kutcher S, Leblanc J, Maclaren C, Hadrava V. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:591–596.

    Article  PubMed  CAS  Google Scholar 

  147. Rawlings MK, Thompson MA, Farthing CF, et al. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34:174–183.

    Article  PubMed  Google Scholar 

  148. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002;288:1594–1602.

    Article  PubMed  Google Scholar 

  149. Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health-Syst Pharm. 2004;61: 364–372.

    PubMed  Google Scholar 

  150. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–437.

    Article  PubMed  CAS  Google Scholar 

  151. Owens D, Carroll A, Fattah S, Clyde Z, Coffey I, Johnstone E. A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatr Scand. 2001; 103:362–369.

    Article  Google Scholar 

  152. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Amer J Health-Syst Pharm. 2003;60:1123–1129.

    Google Scholar 

  153. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc. 2001;41:411–420.

    CAS  Google Scholar 

  154. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–1310.

    Article  PubMed  CAS  Google Scholar 

  155. Esposito L. The effects of medication education on adherence to medication regimens in an elderly population. J Adv Nurs. 1995;21:935–943.

    Article  PubMed  CAS  Google Scholar 

  156. Madoff SA, Pristach CA, Smith CM, Pristach EA. Computerized medication instruction for psychiatric inpatients admitted for acute care. MD Comput. 1996;13:427–431, 441.

    PubMed  CAS  Google Scholar 

  157. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing. 2001;30:33–40.

    Article  PubMed  CAS  Google Scholar 

  158. Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995;160:561–564.

    PubMed  CAS  Google Scholar 

  159. Bennett JW, Glasziou P, DelMar C, De Looze F. A computerized prescribing decision support system to improve patient adherence with prescribing: a randomized controlled trial. Austr Fam Physician. 2003;32:667–671.

    Google Scholar 

  160. Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9:57–64.

    Article  PubMed  CAS  Google Scholar 

  161. Lourens H, Woodward MC. Impact of a medication card on compliance in older people. Aust J Ageing. 1994;13:72–76.

    Google Scholar 

  162. Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. West J Med. 2002;176:92–96.

    PubMed  Google Scholar 

  163. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Controlled Clin Trials. 1997;18:187–203.

    Article  PubMed  CAS  Google Scholar 

  164. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Counsel. 2002;46:93–108.

    Article  Google Scholar 

  165. Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc. 2003;43:668–678.

    Article  Google Scholar 

  166. IOM Committee on Health and Literacy. The extent and associations of limited health literacy. In: Nielsen-Bohlman L, Panzer AM, Kindig DA, eds. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press; 2004:59–107.

    Google Scholar 

  167. Ebrahimzadeh H, Davalos R, Lee PP. Literacy levels of ophthalmic patient education materials. Surv Ophthalmol. 1997;42:152–156.

    Article  PubMed  CAS  Google Scholar 

  168. Ortiz F, Fitten LJ. Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord. 2000;14:141–150.

    Article  PubMed  CAS  Google Scholar 

  169. Weech-Maldonado R, Morales LS, Elliott M, Spritzer K, Marshall G, Hays RD. Race/ethnicity, language, and patients’ assessments of care in Medicaid managed care. Health Serv Res. 2003; 38:789–808.

    Article  PubMed  Google Scholar 

  170. Xu KT, Rojas-Fernandez CH. Ancillary community pharmacy services provided to older people in a largely rural and ethnically diverse region: a survey of consumers in West Texas. J Rural Health. 2003;19:79–86.

    PubMed  Google Scholar 

  171. John-Baptiste A, Naglie G, Tomlinson G, et al. The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med. 2004;19:221–228.

    Article  PubMed  Google Scholar 

  172. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163:83–90.

    Article  PubMed  Google Scholar 

  173. Hussey LC. Minimizing effects of low literacy on medication knowledge and compliance among the elderly. Clin Nurs Res. 1994;3:132–145.

    Article  PubMed  CAS  Google Scholar 

  174. Mulrow C, Bailey S, Sonksen PH, Slavin B. Evaluation of an audiovisual diabetes education program: negative results of a randomized trial of patients with non-insulin-dependent diabetes mellitus. J Gen Intern Med. 1987;2:215–219.

    Article  PubMed  CAS  Google Scholar 

  175. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant therapy. J Am Pharm Assoc. 2002;42:36–43.

    Article  Google Scholar 

  176. Svarstad BL, Bultman DC, Mount JC, Tabak ER. Evaluation of written prescription information provided in community pharmacies: a study in eight states. J Am Pharm Assoc. 2003;43:383–393.

    Article  Google Scholar 

  177. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulations, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44:22–29.

    Article  Google Scholar 

  178. Sleath B, Chewning B, Svarstad B, Roter D. Patient expression of complaints and adherence problems with medications during chronic disease medical visits. J Soc Admin Pharm. 2000;17: 71–80.

    Google Scholar 

  179. Roter D. Advancing the physician’s contribution to enhancing compliance. J Pharmacoepidemiol. 1995;3:37–48.

    Article  Google Scholar 

  180. Haynes RB, McDonald PM, Garg AX. Helping patients follow prescribed treatment. JAMA. 2002; 288:2880–2883.

    Article  PubMed  Google Scholar 

  181. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–386.

    Article  PubMed  CAS  Google Scholar 

  182. Haynes RB. Strategies for enhancing patient compliance. Drug Ther. 1980;January:147–154.

    Google Scholar 

  183. McDonald PM, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication regimens. JAMA. 2002;288:2868–2879.

    Article  PubMed  Google Scholar 

  184. Prochaska JO. Systems of Psychotherapy: A Transtheoretical Analysis. Homewood, Ill: Dorsey Press; 1979.

    Google Scholar 

  185. Di Clemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav. 1982;7:133–142.

    Article  Google Scholar 

  186. Prochaska JO, Di Clemente CC. Common processes of self-change in smoking, weight control and psychological distress. In: Shiffman S, Wills, TA, eds. Coping and Substance Abuse. New York, NY: Academic Press; 345–363.

  187. Norcross JC, Prochaska JO, Di Clemente CC. Self-change of psychological distress: laypersons’ vs psychologists’ coping strategies. J Clin Psychol. 1986;42:834–840.

    Article  PubMed  CAS  Google Scholar 

  188. Di Clemente CC, Hughes SO. Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse. 1990;2:217–235.

    Article  Google Scholar 

  189. Marcus BH, Banspach SW, Lefebvre RC, Rossi JS, Carleton RA, Abrams DB. Using the stages of change model to increase the adoption of physical activity among community participants. Am J Health Promot. 1992;6:424–429.

    PubMed  CAS  Google Scholar 

  190. McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychother Theory Res Pract. 1983;20:368–375.

    Article  Google Scholar 

  191. Swanson AJ, Pantalon MV, Cohen KR. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Dis. 1997;187:630–635.

    Article  Google Scholar 

  192. Liang H. Decreasing Medication Dropout: A Study to Develop and Evaluate Intervention Software Using the Transtheoretical Model of Change and Motivational Interviewing [dissertation]. Auburn, Ala: Auburn University; 2003.

    Google Scholar 

  193. Noel OR. Adherence to Antihypertensive Medication Regimens: An Application of the Fishbein Behavioral Intention Model [dissertation]. Auburn, Ala: Auburn University; 1993.

    Google Scholar 

  194. Cattaneo MJ, Sengupta N, Nichol MB. Factors associated with compliance: analysis of the patient’s health belief model. In: Program and abstracts of the ASHP midyear clinical meeting; December, 1999; Reno, Nev. Abstract P-444E.

  195. Daftary MN, Goolsby T, Dutta A, Delapenha RA. Possible factors influencing non-adherence to antiretrovirals in an ambulatory HIV population. In: Program and abstracts of the ASHP midyear clinical meeting; December 2002; Atlanta, Ga. Abstract p 618E.

  196. Magura S, Laudet AB, Mahmood D, Rosenblum A, Knight E. Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv. 2002;53:310–316.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Wyoming, Dept 3375 1000 E. University Ave., 82071, Laramie, WY

    Kem P. Krueger PharmD, PhD (Academic Professional Lecturer)

  2. Auburn University, Auburn, Alabama

    Bill Felkey MS (Professor of Pharmacy Care Systems)

Authors
  1. Kem P. Krueger PharmD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce A. Berger PhD, RPh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bill Felkey MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krueger, K.P., Berger, B.A. & Felkey, B. Medication adherence and persistence: A comprehensive review. Adv Therapy 22, 313–356 (2005). https://doi.org/10.1007/BF02850081

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850081

Keywords

Search

Navigation